ADVFN - Advanced Financial Network.
Free Real-time News Alerts: Tell us which stocks you're watching and we'll send you the latest news as it is released direct to your e-mail.
News alerts
HOME» AMEX » N » NBY Stock Price

Nbc Capital Stock Price

 Novabay Pharmaceuticals, Inc. Stock Price
NBY Stock Price
 Novabay Pharmaceuticals, Inc. Stock Chart
NBY Stock Chart
 Novabay Pharmaceuticals, Inc. Stock News
NBY Stock News
 Novabay Pharmaceuticals, Inc. Company Information
NBY Company Information
 Novabay Pharmaceuticals, Inc. Stock Trades
NBY Stock Trades
Nbc Capital (NBY)
URL : Nbc Capital
0.79 NBY +0.01
+0.01 (+1.28%)

Company Description : NovaBay Pharmaceuticals, Inc., is a clinical-stage biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market.

Nbc Capital Stock
Share Price0.79
Bid Price-
Ask Price-
% Change+1.28%
Last Change Time20:00:00
Yesterday's Close0.78
Nbc Capital Stock Chart
September 2013 to September 2014
Novabay Pharmaceuticals, Inc. Historical Stock Chart September 2013 to September 2014
More NBY Stock Trades »Nbc Capital : Stock Trades Table
TimePriceSizeTypeBid PriceOffer PriceNumberBuy / Sell
16:36:160.757,900form t0.740.75321B
16:36:060.752,000form t0.740.75320B
16:35:570.75100form t0.740.80319S
15:59:350.79100burst basket0.780.80318B
15:59:350.79100burst basket0.780.80317B
15:59:100.79309burst basket0.780.80316B
15:58:400.79300burst basket0.780.80315B
15:58:050.79283burst basket0.780.80314B
15:58:050.7917basket idx0.780.80313B
15:57:350.79100burst basket0.780.80312B
Live Intraday Nbc Capital Stock Quote
Monday, 01 September 2014
Novabay Pharmaceuticals, Inc. Intraday Stock Chart Monday, 01 September 2014

Nbc Capital and other American Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations